Updated:
Generate Life Sciences
Generate Life Sciences operates a portfolio of reproductive, stem cell, and genetic services brands including California Cryobank and CBR.
Generate Life Sciences
Generate Life Sciences is dedicated to helping more parents have children and access the science they need to protect their family’s future. Learn more.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Los Angeles
Corporate office
Los Angeles, CA, United States
Sector focus
Frequently asked questions
Who owns Generate Life Sciences?
As of 2025, Generate Life Sciences is owned by CooperSurgical, a subsidiary of CooperCompanies (per the firm, 2025). Prior to that, it was privately held by an undisclosed owner or group.
What does Generate Life Sciences do?
Generate Life Sciences operates a family of reproductive and newborn stem cell brands. These include sperm and egg banks, newborn stem cell processing and storage (CBR), genetic screening, and medical device distribution for IVF (Kitazato USA). The company describes itself as a global life sciences firm focused on helping families build and protect healthy children.
Is Generate Life Sciences a family office?
No. Generate Life Sciences is an operating company that owns and manages a collection of fertility and stem cell service brands. It is not a single-family office, multi-family office, or investment manager in the traditional sense.
What is the relationship between Generate Life Sciences and CooperSurgical?
CooperSurgical, a subsidiary of CooperCompanies, acquired Generate Life Sciences in 2025 (per the firm, 2025). Generate now operates as a unit within CooperSurgical's fertility and women's health division.
What brands does Generate Life Sciences include?
Its brands include California Cryobank, NW Cryobank, Donor Egg Bank USA, newborn stem cell bank CBR, IVF medical device company Kitazato USA, and a HIPAA-secure healthcare technology platform for egg donor recruitment (per the firm's website).
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: